Metabolic transformation of DMBA-induced carcinogenesis and inhibitory effect of salvianolic acid B and breviscapine treatment

Journal of Proteome Research

Volumn 11, Issue 2, 2012, Pages 1302-1316

  Wei, Jie ^a   Xie, Guoxiang ^b   Ge, Shuyun ^a   Qiu, Yunping ^b   Liu, Wei ^a   Lu, Aiping ^c   Chen, Tianlu ^d   Li, Houkai ^b   Zhou, Zengtong ^a   Jia, Wei ^b  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b UNIVERSITY OF NORTH CAROLINA AT GREENSBORO   (United States)

^c INSTITUTE OF CHINESE MATERIA MEDICA   (China)

^d Shanghai Jiao Tong University   (China)

Author keywords

7,12 dimethylbenz(a)anthracene; angiogenesis; Breviscapine; carcinogenesis; DMBA; gas chromatography time of flight mass spectrometry; GC TOF MS; metabonomics; oral cancer; Salvianolic acid B

Indexed keywords

ANGIOPOIETIN 1; BREVISCAPINE; DIMETHYLBENZ[A]ANTHRACENE; INOSITOL; INTERLEUKIN 10; SALVIANOLIC ACID B; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; GAS CHROMATOGRAPHY; GENE EXPRESSION; GLYCOLYSIS; HAMSTER; HISTOPATHOLOGY; MOUTH CANCER; MOUTH SQUAMOUS CELL CARCINOMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ANIMALS; BENZOFURANS; CARCINOGENS; CRICETINAE; DRUG INTERACTIONS; FLAVONOIDS; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HISTOCYTOCHEMISTRY; MALE; MESOCRICETUS; METABOLIC NETWORKS AND PATHWAYS; METABOLOME; METABOLOMICS; MOUTH NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC;

CRICETINAE; SALVIA MILTIORRHIZA;

EID: 84863011597     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr2009725     Document Type: Article

References (52)

1. Jemal, A.; Bray, F.; Center, M. M.; Ferlay, J.; Ward, E.; Forman, D. Global Cancer Statistics CA-Cancer J. Clin. 2011, 61 (2) 69-90
2. Zhao, Y.; Guo, Y. H.; Gu, X. B. Salvianolic Acid B, a Potential Chemopreventive Agent, for Head and Neck Squamous Cell Cancer J. Oncol. 2011, 534-48
3. Jemal, A.; Siegel, R.; Xu, J. Q.; Ward, E. Cancer Statistics, 2010 CA-Cancer J. Clin. 2010, 60 (5) 277-300
4. Slaughter, D. P.; Southwick, H. W.; Smejkal, W. Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin Cancer 1953, 6 (5) 963-8
5. Lippman, S. M.; Sudbo, J.; Hong, W. K. Oral cancer prevention and the evolution of molecular-targeted drug development J. Clin. Oncol. 2005, 23 (2) 346-56
6. http://www.maxillofacialcenter.com/BondBook/mucosa/leukoplakia.html.
7. Lumerman, H.; Freedman, P.; Kerpel, S. Oral epithelial dysplasia and the development of invasive squamous cell carcinoma Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 1995, 79 (3) 321-9
8. Zhao, Y.; Hao, Y.; Ji, H.; Fang, Y.; Guo, Y.; Sha, W.; Zhou, Y.; Pang, X.; Southerland, W. M.; Califano, J. A.; Gu, X. Combination effects of salvianolic acid B with low-dose celecoxib on inhibition of head and neck squamous cell carcinoma growth in vitro and in vivo Cancer Prev. Res. (Phila.) 2010, 3 (6) 787-96
9. Zhou, Z. T.; Yang, Y.; Ge, J. P. The preventive effect of salvianolic acid B on malignant transformation of DMBA-induced oral premalignant lesion in hamsters Carcinogenesis 2006, 27 (4) 826-832
10. Shin, D. M. Oral cancer prevention advances with a translational trial of green tea Cancer Prev. Res. (Phila.) 2009, 2 (11) 919-21
11. Yang, Y.; Zhou, Z. T.; Ge, J. P. Effect of genistein on DMBA-induced oral carcinogenesis in hamster Carcinogenesis 2006, 27 (3) 578-83
12. Li, H.; Huang, D.; Gao, Z.; Lv, Y.; Zhang, L.; Cui, H.; Zheng, J. Scutellarin inhibits cell migration by regulating production of alphavbeta6 integrin and E-cadherin in human tongue cancer cells Oncol. Rep. 2010, 24 (5) 1153-60
13. Bao, Y. X.; Wong, C. K.; Leung, S. F.; Chan, A. T. C.; Li, P. W.; Wong, E. L. Y.; Leung, P. C.; Fung, K. P.; Yin, Y. B.; Lam, C. W. K. Clinical studies of immunomodulatory activities of Yunzhi-Danshen in patients with nasopharyngeal carcinoma J. Altern. Complementary Med. 2006, 12 (8) 771-776
14. Liang, X.; Yang, Y.; Deng, C.; Meng, W.; Liu, T.; Jia, Y.; Cheng, Y.; Li, L. [The variation of Caspase3 activity in tanshinone induced NB4 cells apoptosis] Sichuan Da Xue Xue Bao Yi Xue Ban 2003, 34 (3) 549-51
15. Ryu, S. Y.; Lee, C. O.; Choi, S. U. In vitro cytotoxicity of tanshinones from Salvia miltiorrhiza Planta Med. 1997, 63 (4) 339-342
16. Li, P.; J., H. B.; Gong, Y. P. The inhibitory effects of Danshen on adhesion and proliferation of Bcacd885 and Tca8113 J. Modern Stomatol. 1999, 13 (12) 91-94
17. Hao, Y.; Xie, T.; Korotcov, A.; Zhou, Y.; Pang, X.; Shan, L.; Ji, H.; Sridhar, R.; Wang, P.; Califano, J.; Gu, X. Salvianolic acid B inhibits growth of head and neck squamous cell carcinoma in vitro and in vivo via cyclooxygenase-2 and apoptotic pathways Int. J. Cancer 2009, 124 (9) 2200-9
18. Zhou, Z. T.; Jin, Z. G.; Zhang, S. L.; Wang, J.; Li, W. G. A Morphic Study On Erigeron Breviscapus (Vant) Hand-Mazz Affecting Angiogenes is of Golden Hamster Cheek Pouch J. Clin. Stomatol. 2000, 16 (3) 166-169
19. Yan, L.; Huang, H.; Tang, Q. Z.; Zhu, L. H.; Wang, L.; Liu, C.; Bian, Z. Y.; Li, H. L. Breviscapine Protects Against Cardiac Hypertrophy Through Blocking PKC-alpha-Dependent Signaling J. Cell. Biochem. 2010, 109 (6) 1158-71
20. Nicholson, J. K.; Lindon, J. C.; Holmes, E. 'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data Xenobiotica 1999, 29 (11) 1181-9
21. Fiehn, O. Combining genomics, metabolome analysis, and biochemical modelling to understand metabolic networks Comp. Funct. Genomics 2001, 2 (3) 155-68
22. Wei, J.; Xie, G.; Zhou, Z.; Shi, P.; Qiu, Y.; Zheng, X.; Chen, T.; Su, M.; Zhao, A.; Jia, W. Salivary metabolite signatures of oral cancer and leukoplakia Int. J. Cancer 2011, 129 (9) 2207-17
23. Xie, G.; Chen, T.; Qiu, Y.; Shi, P.; Zheng, X.; Su, M.; Zhao, A.; Zhou, Z.; Jia, W. Urine metabolite profiling offers potential early diagnosis of oral cancer Metabolomics 2011, 1-12
24. Weidner, N.; Semple, J. P.; Welch, W. R.; Folkman, J. Tumor angiogenesis and metastasis - correlation in invasive breast carcinoma N. Engl. J. Med. 1991, 324 (1) 1-8
25. Qiu, Y.; Cai, G.; Su, M.; Chen, T.; Zheng, X.; Xu, Y.; Ni, Y.; Zhao, A.; Xu, L. X.; Cai, S.; Jia, W. Serum metabolite profiling of human colorectal cancer using GC-TOFMS and UPLC-QTOFMS J. Proteome Res. 2009, 8 (10) 4844-50
26. Ni, Y.; Su, M.; Qiu, Y.; Chen, M.; Liu, Y.; Zhao, A.; Jia, W. Metabolic profiling using combined GC-MS and LC-MS provides a systems understanding of aristolochic acid-induced nephrotoxicity in rat FEBS Lett. 2007, 581 (4) 707-11
27. Benjamini, Y.; Hochberg, Y. CONTROLLING THE FALSE DISCOVERY RATE-A PRACTICAL AND POWERFUL APPROACH TO MULTIPLE TESTING J. R. Stat. Soc., Ser. B: Methodol. 1995, 57 (1) 289-300
28. Storey, J. D. A direct approach to false discovery rates J. R. Stat. Soc., Ser. B: Stat. Methodol. 2002, 64, 479-98
29. Wise, D. R.; Thompson, C. B. Glutamine addiction: a new therapeutic target in cancer Trends Biochem. Sci. 2010, 35 (8) 427-33
30. Metallo, C. M.; Vander Heiden, M. G. Metabolism strikes back: metabolic flux regulates cell signaling Genes Dev. 2010, 24 (24) 2717-2722
31. Tennant, D. A.; Duran, R. V.; Gottlieb, E. Targeting metabolic transformation for cancer therapy Nat. Rev. Cancer 2010, 10 (4) 267-77
32. Kalhan, S. C.; Mahajan, S.; Burkett, E.; Reshef, L.; Hanson, R. W. Glyceroneogenesis and the source of glycerol for hepatic triacylglycerol synthesis in humans J. Biol. Chem. 2001, 276 (16) 12928-31
33. Forest, C.; Tordjman, J.; Glorian, M.; Duplus, E.; Chauvet, G.; Quette, J.; Beale, E. G.; Antoine, B. Fatty acid recycling in adipocytes: a role for glyceroneogenesis and phosphoenolpyruvate carboxykinase Biochem. Soc. Trans. 2003, 31, 1125-9
34. Sears, D. D.; Hsiao, G.; Hsiao, A.; Yu, J. G.; Courtney, C. H.; Ofrecio, J. M.; Chapman, J.; Subramaniam, S. Mechanisms of human insulin resistance and thiazolidinedione-mediated insulin sensitization Proc. Natl. Acad. Sci. U.S.A. 2009, 106 (44) 18745-50
35. Shimomura, Y.; Murakami, T.; Nakai, N.; Nagasaki, M.; Harris, R. A. Exercise promotes BCAA catabolism: effects of BCAA supplementation on skeletal muscle during exercise J. Nutr. 2004, 134 (6 Suppl) 1583S-7S
36. Cole, J. T.; Mitala, C. M.; Kundu, S.; Verma, A.; Elkind, J. A.; Nissim, I.; Cohen, A. S. Dietary branched chain amino acids ameliorate injury-induced cognitive impairment Proc. Natl. Acad. Sci. U.S.A. 2010, 107 (1) 366-71
37. Sugimoto, M.; Wong, D. T.; Hirayama, A.; Soga, T.; Tomita, M. Capillary electrophoresis mass spectrometry-based saliva metabolomics identified oral, breast and pancreatic cancer-specific profiles Metabolomics 2010, 6 (1) 78-95
38. Bojan, O.; Mustea, I.; Preda, N. [Modification of some free amino acids in the serum of cancer patients under the influence of glucose on tumoral metabolism] Clin. Chim. Acta 1969, 23 (2) 335-40
39. Baracos, V. E.; Mackenzie, M. L. Investigations of branched-chain amino acids and their metabolites in animal models of cancer J. Nutr. 2006, 136 (1 Suppl) 237S-42S
40. Coussens, L. M.; Werb, Z. Inflammation and cancer Nature 2002, 420 (6917) 860-7
41. Mocellin, S.; Marincola, F. M.; Young, H. A. Interleukin-10 and the immune response against cancer: a counterpoint J. Leukoc. Biol. 2005, 78 (5) 1043-51
42. Alas, S.; Emmanouilides, C.; Bonavida, B. Inhibition of interleukin 10 by rituximab results in down-regulation of bcl-2 and sensitization of B-cell non-Hodgkin's lymphoma to apoptosis Clin. Cancer Res. 2001, 7 (3) 709-23
43. Bielecka-Dabrowa, A.; Hannam, S.; Rysz, J.; Banach, M. Malignancy-associated dyslipidemia Open Cardiovasc. Med. J. 2011, 5, 35-40
44. Lohe, V. K.; Degwekar, S. S.; Bhowate, R. R.; Kadu, R. P.; Dangore, S. B. Evaluation of correlation of serum lipid profile in patients with oral cancer and precancer and its association with tobacco abuse J. Oral Pathol. Med. 2010, 39 (2) 141-8
45. Williams, R. R.; Sorlie, P. D.; Feinleib, M.; McNamara, P. M.; Kannel, W. B.; Dawber, T. R. Cancer incidence by levels of cholesterol J. Am. Med. Assoc. 1981, 245 (3) 247-52
46. Han, W.; Gills, J. J.; Memmott, R. M.; Lam, S.; Dennis, P. A. The Chemopreventive Agent Myoinositol Inhibits Akt and Extracellular Signal-Regulated Kinase in Bronchial Lesions from Heavy Smokers Cancer Prev. Res. 2009, 2 (4) 370-6
47. Kassie, F.; Melkamu, T.; Endalew, A.; Upadhyaya, P.; Luo, X.; Hecht, S. S. Inhibition of lung carcinogenesis and critical cancer-related signaling pathways by N-acetyl-S-(N-2-phenethylthiocarbamoyl)-l-cysteine, indole-3-carbinol and myo-inositol, alone and in combination Carcinogenesis 2010, 31 (9) 1634-41
48. Nishino, H.; Murakoshi, M.; Masuda, M.; Tokuda, H.; Satomi, Y.; Onozuka, M.; Yamaguchi, S.; Bu, P.; Tsuruta, A.; Nosaka, K.; Baba, M.; Takasuka, N. Suppression of lung and liver carcinogenesis in mice by oral administration of myo-inositol Anticancer Res. 1999, 19 (5A) 3663-4
49. Holash, J.; Maisonpierre, P. C.; Compton, D.; Boland, P.; Alexander, C. R.; Zagzag, D.; Yancopoulos, G. D.; Wiegand, S. J. Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF Science 1999, 284 (5422) 1994-8
50. Stoeltzing, O.; Ahmad, S. A.; Liu, W.; McCarty, M. F.; Wey, J. S.; Parikh, A. A.; Fan, F.; Reinmuth, N.; Kawaguchi, M.; Bucana, C. D.; Ellis, L. M. Angiopoietin-1 inhibits vascular permeability, angiogenesis, and growth of hepatic colon cancer tumors Cancer Res. 2003, 63 (12) 3370-7
51. Ross, J. S.; Kaur, P.; Sheehan, C. E.; Fisher, H. A. G.; Kaufman, R. A.; Kallakury, B. V. S. Prognostic significance of matrix metalloproteinase 2 and tissue inhibitor of metalloproteinase 2 expression in prostate cancer Modern Pathol. 2003, 16 (3) 198-205
52. O-charoenrat, P.; Khantapura, P. The role of genetic polymorphisms in the promoters of the matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 genes in head and neck cancer Oral Oncol. 2006, 42 (3) 257-67